U.S. Markets closed

The Zacks Analyst Blog Highlights: inTest, Progressive, BioTelemetry, Bausch Health and Steelcase

Zacks Equity Research
Abiomed (ABMD) closed at $324.13 in the latest trading session, marking a -0.45% move from the prior day.

For Immediate Release

Chicago, IL – January 7, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: inTest Corp. INTT, The Progressive Corp. PGR, BioTelemetry BEAT, Bausch Health Cos BHC and Steelcase SCS.

Here are highlights from Friday’s Analyst Blog:

Bull or Bear, Your Investment Strategy for 2019

The longest bull market in history has taken both experts and novices by surprise. So every now and then, there is this conversation about the possibilities of a recession and what we should do to prepare for it. There have been many such conversations through 2018, but a recession never materialized, as the market and the government appear to have gotten smarter at aversion. Or at least at ensuring that earlier indicators won’t be valid this time around.

Take the lead indicator yield curve inversion for example. In an expanding economy, government bond yields surpass short-term yields because of greater optimism about the future. When short term yields exceed long term yields, the inversion is an indication of uncertainty about the future.

But monetary policy has effectively kept long term rates low so bond yields remain attractive and spending by both the government and corporations can continue. Still, the gap between 10-year and 2-year yields continues to narrow, indicating that a bear market may be in the offing.

Another indicator is a pickup in M&A activity, which is a typical occurrence toward the end of the business cycle. But M&A has been robust in the last few years with no signs of a bear market. The last year has seen a fresh spate of activity, but since companies aren’t in distress, this may or may not be a valid signal.

The story appears even more positive if you consider the high-yield spread, which is the difference between the yields in below-investment-grade corporate debt and “risk-free” U.S. Treasuries. When the economy is strong, the gap/spread is typically smaller as the risk of doing business is relatively low.

As recession fears near, however, opportunities shrink and it becomes harder to do business. As a result, companies need to pay more for significantly riskier ventures. The high-yield spread has risen during the last two recessions, but as the chart below shows, it remains at acceptable levels right now.

An increase in weekly jobless claims (first-time claims for state unemployment benefits) is another strong and obvious indicator of a recession. But while jobless claims increased in the last week of the year, it makes sense to study the trend rather than what happened in a single week.

And despite the usual ups and downs, weekly jobless claims continue to trend down steadily since the last recession. Other than the record low unemployment rate, lower taxes and lower oil prices continue to support consumer liquidity.  

Persistently declining stock or index valuations can also indicate a broader market slowdown. The following table shows sector valuations for the historical period wherein downward pressure across sectors is apparent. But significant declines (of 20% or more) are seen in less than half the sectors.

Moreover, the bigger sectors (medical, technology, finance) are holding up better, indicating some positive sentiment around growth. Oil/Energy and Transport sectors are borderline cases.

As detailed in the current earnings trends report, total Q4 earnings for the S&P 500 index are expected to be up 11.8% from the year-ago quarter on revenues that are expected to be up 5.6%. This however is down from +15.9% growth expected at the start of the quarter and further declines can’t be ruled out.

The negative revisions trend is widespread, with estimates for 15 of the 16 Zacks sectors coming down during the quarter. The Conglomerates, Construction, Energy and Consumer Discretionary sectors have seen the biggest downward revisions while Transportation continued to benefit from lower oil prices.

Investment Strategy for 2019

The mixed signals in the above message means that while we don’t need to bail out of the market right away (or at all), a defensive strategy may be the best way to go.

The first leg of that strategy is a focus on Zacks Rank #1 stocks, since the rank has historically outperformed the market by a wide margin.

At the onset of a recession, it is better to get into defensive sectors, but as evident from the above, it is the growth sectors that are holding up relatively better in the current environment.

So finding stocks like inTest Corp. in the Technology sector that offer growth at attractive valuations may be a good idea.

Finance is another area with plenty of opportunities. So stocks like The Progressive Corp. are worth buying.

Growth opportunities abound in the medical sector, but BioTelemetry stand out. A value pick like Bausch Health Cos is also worth considering.

Utilities and Business Services are good defensive sectors but there are fewer opportunities. So Steelcase is one of the only ones catching the eye.

Conclusion

The bears may not have taken over yet, but there are strong enough signs that they may not be too far away. So the strong economic growth, healthy labor market, low inflation and interest rates, and GDP growth that are the hallmarks of a bull market may gradually give way. Let’s hope for the best and prepare for the worst.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                                   

https://www.zacks.com                                                 

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
inTest Corporation (INTT) : Free Stock Analysis Report
 
Steelcase Inc. (SCS) : Free Stock Analysis Report
 
The Progressive Corporation (PGR) : Free Stock Analysis Report
 
BioTelemetry, Inc. (BEAT) : Free Stock Analysis Report
 
Bausch Health Cos Inc. (BHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research